Auspex is a biopharmaceutical company that develops and commercializes medicines for the treatment of orphan hyperkinetic movement disorders.
Business Model:
Revenue: $5M
Employees: 11-50
Auspex Pharmaceuticals was acquired by
Teva Pharmaceutical Industries.
The acquisition happend on 2015-03-30.
Details of the transaction were not public
Address: 3333 N Torrey Pines Ct
City: La Jolla
State: CA
Zip: 92037
Country: US
Auspex is a biopharmaceutical company that develops and commercializes medicines for the treatment of orphan hyperkinetic movement disorders.
Contact Phone:
+18585582400
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
2/6/2014
IPO Valuation:
$270M
Ticker Symbol:
ASPX
IPO Price:
$12/share
Amount Raised:
$84M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|